Capricor Therapeutics' (CAPR) shares were up more than 4% in Monday trading after B. Riley upgraded the biotechnology company's stock to buy from neutral, and raised its price target to $21 from $5.
Trading volume stood at over 2 million shares, compared with a daily average of roughly 6.4 million.
Price: $8.73, Change: $+0.36, Percent Change: +4.30%